| Contributors: |
Bousquet, J.; Sousa-Pinto, B.; Anto, J.M.; Bedbrook, A.; Czarlewski, W.; Ansotegui, I.J.; Bergmann, K.-.; Braido, F.; Brussino, L.; Cecchi, L.; Loureiro, C.C.; Cruz, A.A.; Devillier, P.; Fiocchi, A.; Gemicioglu, B.; Haahtela, T.; Ivancevich, J.C.; Klimek, L.; Kulus, M.; Kuna, P.; Kupczyk, M.; Kvedariene, V.; Larenas-Linnemann, D.E.; Louis, G.; Louis, R.; Makris, M.; Morais-Almeida, M.; Niedoszytko, M.; Ohta, K.; Ollert, M.; Papadopoulos, N.; Patella, V.; Petre, B.; Pfaar, O.; Puggioni, F.; Quirce, S.; Regateiro, F.S.; Roche, N.; Rouadi, P.W.; Samolinski, B.; Sastre, J.; Schleich, F.; Scichilone, N.; Taborda-Barata, L.; Toppila-Salmi, S.; Valiulis, A.; Vardaloglu Koyuncu, I.; Ventura, M.T.; Yorgancioglu, A.; Fonseca, J.A.; Zuberbier, T. |
| Description: |
Patient-reported outcome measures (PROMs) are used to assess a patient's health status at a particular point in time. They are essential in the development of person-centred care. This paper reviews studies performed on PROMs for assessing AR and asthma control, in particular VAS scales that are included in the app MASK-air® (Mobile Airways Sentinel networK) for asthma and rhinitis. VASs were initially developed on paper and pencil and tested for their criterion validity, cut-offs and responsiveness. Then, a multicentric, multinational, double-blind, placebo-controlled, randomised control trial (DB-PC-RCT) using an electronic VAS form was carried out. Finally, with the development of MASK-air® in 2015, previously validated VAS questions were adapted to the digital format and further methodologic evaluations were performed. VAS for asthma, rhinitis, conjunctivitis, work and EQ-5D are included in the app. Additionally, two control-medication scores for allergic symptoms of asthma (e-DASTHMA) were validated for their criterion validity, cut-offs and responsiveness. |